Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Rho-associated protein kinase 1 | ||
Ligand | BDBM50450840 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1743831 (CHEMBL4178341) | ||
IC50 | 130±n/a nM | ||
Citation | Kurasawa, O; Oguro, Y; Miyazaki, T; Homma, M; Mori, K; Iwai, K; Hara, H; Skene, R; Hoffman, I; Ohashi, A; Yoshida, S; Ishikawa, T; Cho, N Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones. Bioorg Med Chem25:2133-2147 (2017) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Rho-associated protein kinase 1 | |||
Name: | Rho-associated protein kinase 1 | ||
Synonyms: | ROCK-I | ROCK1 | ROCK1_HUMAN | Renal carcinoma antigen NY-REN-35 | Rho-associated protein kinase | Rho-associated protein kinase 1 (ROCK1) | Rho-associated, coiled-coil-containing protein kinase 1 | Rho-associated, coiled-coil-containing protein kinase I | Rho-kinase (ROCK I) | Serine/threonine-protein kinase RIO1 | p160 ROCK-1 | p160ROCK | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 158156.77 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q13464 | ||
Residue: | 1354 | ||
Sequence: |
| ||
BDBM50450840 | |||
n/a | |||
Name | BDBM50450840 | ||
Synonyms: | CHEMBL4204333 | ||
Type | Small organic molecule | ||
Emp. Form. | C21H21FN4O2S | ||
Mol. Mass. | 412.48 | ||
SMILES | Cc1n[nH]cc1-c1cc2N[C@]3(CC[C@@](O)(CC3)c3ccc(F)cc3)NC(=O)c2s1 |r,wU:10.11,wD:13.14,(20.26,-53.26,;19.79,-51.8,;18.32,-51.32,;18.32,-49.78,;19.79,-49.31,;20.69,-50.55,;22.23,-50.54,;23.14,-51.8,;24.62,-51.32,;25.95,-52.08,;27.27,-51.32,;27.26,-52.86,;28.58,-53.63,;29.92,-52.87,;30.69,-54.2,;29.93,-51.33,;28.6,-50.55,;31.46,-52.87,;32.23,-54.2,;33.77,-54.21,;34.54,-52.87,;36.08,-52.87,;33.76,-51.53,;32.22,-51.54,;27.28,-49.78,;25.95,-49,;25.95,-47.46,;24.62,-49.77,;23.14,-49.29,)| | ||
Structure |